Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $26.0000 (-4.48%) ($25.8300 - $27.3500) on Fri. May. 10, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.52% (three month average) | RSI | 40 | Latest Price | $26.0000(-4.48%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -5.2% a day on average for past five trading days. | Weekly Trend | ATRA declines -3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(56%) ARKG(49%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -2.26% in a week (0% probabilities). UUP(-14%) VXX(-13%) TLT(-13%) VIXM(-10%) UNG(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.26% (StdDev 4.52%) | Hourly BBV | 0 () | Intraday Trend | -4.9% | | | |
|
1 - 5 Day Possible Target | $17.44(-32.92%) | Resistance Level | $33.11 | 5 Day Moving Average | $31.44(-17.3%) | 10 Day Moving Average | $32.53(-20.07%) | 20 Day Moving Average | $33.11(-21.47%) | To recent high | -37.7% | To recent low | 0% | Market Cap | $1.932b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |